PH21991A - 1-((aminoalkyl and aminoalkylamino)carbonyl and thiobarbonyl) diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles, their method of use and pharmaceutical composition containing them - Google Patents
1-((aminoalkyl and aminoalkylamino)carbonyl and thiobarbonyl) diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles, their method of use and pharmaceutical composition containing themInfo
- Publication number
- PH21991A PH21991A PH32936A PH32936A PH21991A PH 21991 A PH21991 A PH 21991A PH 32936 A PH32936 A PH 32936A PH 32936 A PH32936 A PH 32936A PH 21991 A PH21991 A PH 21991A
- Authority
- PH
- Philippines
- Prior art keywords
- homopiperidineacetamides
- aminoalkylamino
- acetonitriles
- aminoalkyl
- piperidine
- Prior art date
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title abstract 4
- SGNIOVNJCXQXOD-UHFFFAOYSA-N 2-(azepan-1-yl)acetamide Chemical class NC(=O)CN1CCCCCC1 SGNIOVNJCXQXOD-UHFFFAOYSA-N 0.000 title abstract 2
- 125000005122 aminoalkylamino group Chemical group 0.000 title abstract 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 title abstract 2
- 125000004103 aminoalkyl group Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Chemical group 0.000 abstract 1
- 230000003288 anthiarrhythmic effect Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/662,583 US4594343A (en) | 1984-10-19 | 1984-10-19 | 1-[(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl]-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH21991A true PH21991A (en) | 1988-05-02 |
Family
ID=24658311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH32936A PH21991A (en) | 1984-10-19 | 1985-10-16 | 1-((aminoalkyl and aminoalkylamino)carbonyl and thiobarbonyl) diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles, their method of use and pharmaceutical composition containing them |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4594343A (de) |
| EP (1) | EP0178947B1 (de) |
| JP (1) | JPS61100563A (de) |
| KR (1) | KR900001204B1 (de) |
| AT (1) | ATE56953T1 (de) |
| AU (1) | AU584931B2 (de) |
| CA (1) | CA1242439A (de) |
| DE (1) | DE3579883D1 (de) |
| IL (1) | IL76586A (de) |
| PH (1) | PH21991A (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0177078A1 (de) * | 1984-09-12 | 1986-04-09 | Duphar International Research B.V | Spasmolytisch wirksame tertiäre Aminderivate und Verfahren zu ihrer Herstellung |
| US4960776A (en) * | 1987-01-28 | 1990-10-02 | A. H. Robins Company, Inc. | 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides |
| DE3744024A1 (de) * | 1987-12-24 | 1989-07-06 | Hoechst Ag | Fluessigkristalline, in 1-stellung substituierte piperidin-4-carbonsaeureester, verfahren zu ihrer herstellung und ihre verwendung in fluessigkristallinen mischungen |
| GB8825505D0 (en) * | 1988-11-01 | 1988-12-07 | Pfizer Ltd | Therapeutic agents |
| US5932594A (en) * | 1988-11-01 | 1999-08-03 | Pfizer, Inc. | Muscarinic receptor antagonists |
| GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
| US5169855A (en) * | 1990-03-28 | 1992-12-08 | Du Pont Merck Pharmaceutical Company | Piperidine ether derivatives as psychotropic drugs or plant fungicides |
| JP4057088B2 (ja) * | 1996-04-22 | 2008-03-05 | 株式会社カネカ | ピロリジン誘導体の製造方法 |
| US6693202B1 (en) | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
| TW200800953A (en) * | 2002-10-30 | 2008-01-01 | Theravance Inc | Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine |
| JP4767842B2 (ja) * | 2003-04-01 | 2011-09-07 | セラヴァンス， インコーポレーテッド | β２アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物 |
| TW200510298A (en) * | 2003-06-13 | 2005-03-16 | Theravance Inc | Substituted pyrrolidine and related compounds |
| WO2005007645A1 (en) * | 2003-07-11 | 2005-01-27 | Theravance, Inc. | Substituted 4-amino-1-benzylpiperidine compounds |
| EP1723142A1 (de) * | 2004-03-11 | 2006-11-22 | Theravance, Inc. | Als antagonisten des muskarinrezeptors geeignete diphenylmethylverbindungen |
| EP1725525A1 (de) * | 2004-03-11 | 2006-11-29 | Theravance, Inc. | Als muscarinrezeptorantagonisten geeignete diphenylmethylverbindungen |
| AU2005294123C1 (en) * | 2004-10-07 | 2010-01-21 | Vitae Pharmaceuticals, Inc. | Diaminoalkane aspartic protease inhibitors |
| TWI411607B (zh) * | 2005-11-14 | 2013-10-11 | Vitae Pharmaceuticals Inc | 天門冬胺酸蛋白酶抑制劑 |
| CL2007002689A1 (es) | 2006-09-18 | 2008-04-18 | Vitae Pharmaceuticals Inc | Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras. |
| JP5450387B2 (ja) * | 2008-04-02 | 2014-03-26 | 株式会社カネカ | （ｓ）−３−（１−シアノ−１，１−ジフェニルメチル）−ピロリジンの製造法 |
| EP2236509A1 (de) | 2009-04-01 | 2010-10-06 | Ragactives, S.L. | Methode zur Herstellung von 1,3-difunktionalisierten Pyrrolidin-Derivaten |
| AR077692A1 (es) | 2009-08-06 | 2011-09-14 | Vitae Pharmaceuticals Inc | Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2409829A (en) * | 1944-04-04 | 1946-10-22 | Ici Ltd | Alkylene-bis-ureas |
| NL88063C (de) * | 1950-12-05 | |||
| US2654754A (en) * | 1950-12-16 | 1953-10-06 | American Home Prod | Substituted glycinamides |
| US3109845A (en) * | 1960-02-04 | 1963-11-05 | Thomae Gmbh Dr K | 1-cyclohexyl, 1-cyclohexenyl, 1-furyl, and 1-thienyl, tertiary amino substituted methanes |
| US3247222A (en) * | 1962-12-26 | 1966-04-19 | Robins Co Inc A H | Alpha (nu-hydrocarbonpyrrolidyl-3-) alpha, alpha carbocyclic arylacetamides |
| GB1057145A (en) * | 1963-08-16 | 1967-02-01 | Bellon Labor Sa Roger | Phenylcyclohexylacetonitrile derivatives |
| GB1178400A (en) * | 1966-12-13 | 1970-01-21 | Delalande Sa | Nitrogen Substituted Amines and their process of Preparation. |
| US3585204A (en) * | 1968-09-19 | 1971-06-15 | Searle & Co | Alpha,alpha-diphenylpiperidineacetic acids and congeners |
| US4017630A (en) * | 1970-08-17 | 1977-04-12 | The Upjohn Company | Certain diphenylalkanoamides used as bird and murine repellents |
| US3998965A (en) * | 1973-12-15 | 1976-12-21 | Aspro-Nicholas Limited | 4-Aminoalkyl-4-cyano-4-phenyl-butanoic acid esters |
| US4361573A (en) * | 1974-03-04 | 1982-11-30 | Temmler Ag | α,α-Diaryl-β-(tert-amino)-propanols and diuretic pharmaceutical compositions containing them |
| US3987201A (en) * | 1974-12-24 | 1976-10-19 | Eli Lilly And Company | Method for treating arrhythmia |
| US4002766A (en) * | 1974-12-26 | 1977-01-11 | A. H. Robins Company, Incorporated | Antiarrhythmia methods |
| GB2002748B (en) * | 1977-05-23 | 1982-01-06 | Ici Ltd | Cardiac stimulants |
| US4277471A (en) * | 1979-03-12 | 1981-07-07 | Eli Lilly And Company | 1,1-Biphenyl-2-yl alkylamines, formulations and antiarrhythmic treatment |
| DE3270905D1 (en) * | 1981-12-17 | 1986-06-05 | Haessle Ab | Para-substituted 3-phenoxy-1-carbonylaminoalkylamino-propan-2-ols having beta receptor blocking properties |
-
1984
- 1984-10-19 US US06/662,583 patent/US4594343A/en not_active Expired - Fee Related
-
1985
- 1985-10-04 IL IL76586A patent/IL76586A/xx unknown
- 1985-10-16 PH PH32936A patent/PH21991A/en unknown
- 1985-10-18 DE DE8585307559T patent/DE3579883D1/de not_active Expired - Fee Related
- 1985-10-18 EP EP85307559A patent/EP0178947B1/de not_active Expired - Lifetime
- 1985-10-18 CA CA000493333A patent/CA1242439A/en not_active Expired
- 1985-10-18 AU AU48907/85A patent/AU584931B2/en not_active Ceased
- 1985-10-18 AT AT85307559T patent/ATE56953T1/de not_active IP Right Cessation
- 1985-10-18 KR KR1019850007676A patent/KR900001204B1/ko not_active Expired
- 1985-10-19 JP JP60234392A patent/JPS61100563A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR900001204B1 (ko) | 1990-02-28 |
| EP0178947A3 (en) | 1987-09-02 |
| IL76586A (en) | 1988-09-30 |
| AU584931B2 (en) | 1989-06-08 |
| EP0178947A2 (de) | 1986-04-23 |
| DE3579883D1 (de) | 1990-10-31 |
| ATE56953T1 (de) | 1990-10-15 |
| JPS61100563A (ja) | 1986-05-19 |
| KR860003221A (ko) | 1986-05-21 |
| EP0178947B1 (de) | 1990-09-26 |
| AU4890785A (en) | 1986-04-24 |
| CA1242439A (en) | 1988-09-27 |
| US4594343A (en) | 1986-06-10 |
| IL76586A0 (en) | 1986-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH21991A (en) | 1-((aminoalkyl and aminoalkylamino)carbonyl and thiobarbonyl) diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles, their method of use and pharmaceutical composition containing them | |
| IL75077A0 (en) | N,3-disubstituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing them | |
| ATE81457T1 (de) | Arylamido (und arylthioamido)-azabicycloalkane zur steigerung des erinnerungsvermoegens oder zur behebung von gedaechtnisschwaeche. | |
| MY107474A (en) | Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents. | |
| ES8501362A1 (es) | Un procedimiento para la preparacion de nuevos derivados arilfenolicos. | |
| NZ216869A (en) | Heterocyclic compounds and pesticidal compositions | |
| IL94027A0 (en) | Diaminoethylene compounds | |
| HUT49847A (en) | Fungicides comprising n-(phenylalkyl)-benzamide derivatives as active ingredient | |
| ES8800168A1 (es) | Procedimiento para preparar derivados de carbamoilimidazol fungicidas | |
| MY101447A (en) | Pesticidal compositions | |
| EG17752A (en) | Benzoylurea derivatives | |
| GB8432144D0 (en) | Organic compounds | |
| ZA84697B (en) | Aryloxy-n-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity | |
| DK0494604T3 (da) | 1-Piperazinyl-2-butener og -2-butyner, mellemprodukter derfor, en fremgangsmåde til fremstilling deraf og deres anvendelse | |
| ES8303308A1 (es) | "un procedimiento para preparar derivados de urea y tiourea". | |
| DE3163803D1 (en) | 2-methyl-5-thiazole-methylamine and carboxamide derivatives | |
| HUT53487A (en) | Fungicide compositions containing nitrogen-containing heterocyclic compounds as active components and process for producing the active components | |
| DK42784A (da) | Pyridin-pyrimidinon-derivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser | |
| GB2182934B (en) | Piperidine derivatives |